Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 977-990

  Zapata, Heidi J ^a   Nakatsugawa, Masako ^a   Moffat, Jennifer F ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FIBROBLAST; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PREPUCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; VARICELLA ZOSTER VIRUS; VIRION; VIRUS REPLICATION;

CELL LINE; ENZYME ACTIVATION; FIBROBLASTS; HERPESVIRUS 3, HUMAN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAP KINASE KINASE 7; PROTO-ONCOGENE PROTEINS C-JUN; VIRION;

HUMAN HERPESVIRUS 3;

EID: 33846048855     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01470-06     Document Type: Article

References (74)

1. Arvin, A. 1996. Varicella-zoster virus, p. 2547-2585. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
2. Babich, H., A. Sedletcaía, and B. Kenigsberg. 2002. In vitro cytotoxicity of protocatechuic acid to cultured human cells from oral tissue: involvement in oxidative stress. Pharmacol. Toxicol. 91:245-253.
3. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S. S. Bhagwat, A. M. Manning, and D. W. Anderson. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98:13681-13686.
4. Bonny, C., A. Oberson, S. Negri, C. Sauser, and D. F. Schorderet. 2001. Cell-permeable peptide inhibitors of JNK: novel blockers of B-cell death. Diabetes 50:77-82.
5. - viruses. J. Virol. 80:4528-4537.
6. Cavigelli, M., F. Dolfi, F.-X. Claret, and M. Karin. 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14:5957-5964.
7. Chen, J. J., Z. Zhu, A. A. Gershon, and M. D. Gershon. 2004. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 119:915-926.
8. Chen, S.-Y., J. Lu, Y.-C. Shih, and C.-H. Tsai. 2002. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J. Virol. 76:9556-9561.
9. Chen, Z., T. B. Gibson, F. Robinson, L. Silvestro, G. Pearson, B. Xu, A. Wright, C. Vanderbilt, and M. H. Cobb. 2001. MAP kinases. Chem. Rev. 101:2449-2476.
10. Coen, D. M., and P. A. Schaffer. 2003. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat. Rev. Drug Discov. 2:278-288.
11. Damania, B., J.-K. Choi, and J. U. Jung. 2000. Signaling activities of gammaherpesvirus membrane proteins. J. Virol. 74:1593-1601.
12. Davis, R. J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.
13. Derijard, B., M. Hibi, I.-H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK 1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
14. Diao, L., B. Zhang, C. Xuan, S. Sun, K. Yang, Y. Tang, W. Qiao, Q. Chen, Y. Geng, and C. Wang. 2005. Activation of c-Jun N-terminal kinase (JNK) pathway by HSV-1 immediate early protein ICP0. Exp. Cell Res. 308:196-210.
15. Dykstra, M. J., and L. E. Reuss. 2003. Biological electron microscopy: theory, techniques, and troubleshooting, 2nd ed. Kluwer Academic/Plenum Publishers, New York, NY.
16. Edmunds, J. W., and L. C. Mahadevan. 2006. Protein kinases seek close encounters with active genes. Science 313:449-451.
17. Eliopoulos, A. G., and L. S. Young. 1998. Activation of the c-Jun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP 1). Oncogene 16:1731-1742.
18. Evers, D. L., X. Wang, and E.-S. Huang. 2004. Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect. 6:1084-1093.
19. Favoreel, H. W., G. Van Minnebrugen, D. Adriaensen, and H. J. Nauwynck. 2005. Cytoskeletal rearrangements and cell extensions induced by the US3 kinase of an alphaherpesvirus are associated with enhanced spread. Proc. Natl. Acad. Sci. USA 102:8990-8995.
20. Galdiero, S., M. Vitiello, M. D'Isanto, E. Di Niola, L. Peluso, K. Raieta, C. Pedone, M. Galdiero, and E. Benedetti. 2004. Induction of signaling pathways by herpes simplex virus type 1 through glycoprotein H peptides. Biopolymers 76:494-502.
21. Gershon, A. A., D. L. Sherman, Z. Zhu, C. A. Gabel, R. T. Ambron, and M. D. Gershon. 1994. Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. J. Virol. 68:6372-6390.
22. Greber, U. F. 2002. Signalling in viral entry. Cell. Mol. Life Sci. 59:608-626.
23. Hamza, S. M., R. A. Reyes, Y. Izumiya, R. Wisdom, H.-J. Kung, and P. A. Luciw. 2004. ORF36 protein kinase of Kaposi's sarcoma herpesvirus (KSHV) activates the c-Jun N-terminal kinase (JNK) signaling pathway. J. Biol. Chem. 279:38325-38330.
24. Hargett, D., T. Mclean, and S. L. Bachenheimer. 2005. Herpes simplex virus ICP27 activation of stress kinases JNK and p38. J. Virol. 79:8348-8360.
25. Harson, R., and C. Grose. 1995. Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J. Virol. 69:4994-5010.
26. 2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 333:324-336.
27. Heo, Y. S., S. K. Kim, C. I. Seo, Y. K. Kim, B. J. Sung, H. S. Lee, J. I. Lee, S. Y. Park, J. H. Kim, K. Y. Hwang, Y. L. Hyun, Y. H. Jeon, S. Ro, J. M. Cho, T. G. Lee, and C. H. Yang. 2004. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J. 23:2185-2195.
28. Hood, C., A. L. Cunningham, B. Slobedman, R. A. Boadle, and A. Abendroth 2003. Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response. J. Virol. 77:12852-12864.
29. Huang, C., Z. Rajfur, C. Borchers, M. D. Schaller, and K. Jacobson, 2003. JNK phosphorylates paxillin and regulates cell migration. Nature 424:219-223.
30. Ip, T. Y., and R. J. Davis. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol. 10:205-219.
31. Karin, M., and E. Gallagher. 2005. From JNK to pay dirt: JNK kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57:283-295.
32. Karin, M., Z.-G. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240-246.
33. Kieser, A., E. Kilger, O. Gires, M. Ueffing, W. Kolch, and W. Hammerschmidt. 1997. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J. 16:6478-6485.
34. Kinchington, P., and J. I. Cohen. 2000. Varicella-zoster virus proteins, p. 556. In A. M. Arvin and A. A. Gershon (ed.), Varicella-zoster virus: virology and clinical management, 1st ed. Cambridge University Press, Cambridge, United Kingdom.
35. Kinchington, P., G. Inchauspe, J. H. Subak-Sharpe, F. Robey, J. Hay, and W. T. Ruyechan. 1988. Identification and characterization of a varicella-zoster virus DNA-binding protein by using antisera directed against a predicted synthetic oligopeptide. J. Virol. 62:802-809.
36. Kinchington, P. R., D. Bookey, and S. E. Turse. 1995. The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles. J. Virol. 69:4274-4282.
37. Kinchington, P. R., K. Fite, A. Seman, and S. E. Turse. 2001. Virion association of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, requires expression of the VZV open reading frame 66 protein kinase. J. Virol. 75:9106-9113.
38. Kinchington, P. R., K. Fite, and S. E. Turse. 2000. Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J. Virol. 74:2265-2277.
39. Kinchington, P. R., J. K. Hougland, A. M. Arvin, W. T. Ruyechan, and J. Hay. 1992. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J. Virol. 66:359-366.
40. Kinchington, P. R., and S. E. Turse. 1998. Regulated nuclear localization of the varicella-zoster virus major regulatory protein, IE62. J. Infect. Dis. 178: S16-S21.
41. Kyriakis, J. M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807-859.
42. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160.
43. Lawler, S., Y. Fleming, M. Goedert, and P. Cohen. 1998. Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr. Biol. 8:1387-1390.
44. Leisenfelder, S. A., and J. F. Moffat. 2006. Varicella-zoster infection of human foreskin fibroblast cells results in atypical cyclin expression and cyclin-dependent kinase activity. J. Virol. 80:5577-5587.
45. Litwin, V., W. Jackson, and C. Grose. 1992. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J. Virol. 66:3643-3651.
46. Ludwig, S., S. Pleschka, and T. Wolff. 2003. Influenza-virus- induced signaling cascades: targets for antiviral therapy? Trends Mol. Med. 9:46-52.
47. MacCorkle, R. A., and T.-H. Tan. 2005. Mitogen-activated protein kinases in cell-cycle control. Cell Biochem. Biophys. 43:451-461.
48. Manning, A. M., and R. J. Davis. 2003. Targeting JNK for therapeutic benefit: from junk to gold? Nature 2:554-565.
49. McLean, T. I., and S. L. Bachenheimer. 1999. Activation of c-Jun N-terminal kinase by herpes simplex virus type 1 enhances viral replication. J. Virol. 73:8415-8426.
50. Minden, A., A. Lin, F.-X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases and Cdc42Hs. Cell 81:1147-1157.
51. Moffat, J. F., M. A. McMichael, S. A. Leisenfelder, and S. L. Taylor. 2004. Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis. Biochim. Biophys. Acta 1697:225-231.
52. Morrison, D. K., and R. J. Davis. 2003. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19: 91-118.
53. Narayanan, A., M. L. Noguiera, W. T. Ruyechan, and T. M. Kristie. 2005. Combinatorial transcription of herpes simplex virus and varicella zoster virus immediate early genes is strictly determined by the cellular coactivator HCF-1. J. Biol. Chem. 280:1369-1375.
54. Niizuma, T., L. Zerboni, M. H. Sommer, H. Ito, S. Hinchcliffe, and A. M. Arvin. 2003. Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF 65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J. Virol. 77:6062-6065.
55. Pan, H., J. Xie, F. Ye, and S.-J. Gao. 2006. Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection. J. Virol. 80:5371-5382.
56. Panteva, M., H. Korkaya, and S. Jameel. 2003. Hepatitis viruses and the MAPK pathway: is this a survival strategy? Virus Res. 92:131-140.
57. Peng, H., H. He, J. Hay, and W. T. Ruyechan. 2003. Interaction between the varicella zoster virus IE62 major transactivator and cellular transcription factor Sp1. J. Biol. Chem. 278:38068-38075.
58. Perkins, D., K. A. Gyure, E. F. Pereira, and L. Aurelian. 2003. Herpes simplex virus type 1-induced encephalitis has an apoptotic component associated with activation of c-Jun N-terminal kinase. J. Neurovirol. 9:101-111.
59. Qi, M., and E. A. Elion. 2005. MAP kinase pathways. J. Cell Sci. 118:3569-3572.
60. Rahaus, M., N. Desloges, M. Yang, W. T. Ruyechan, and M. H. Wolff. 2003. Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication. J. Gen. Virol. 84:2957-2967.
61. Rahaus, M., N. Desloges, and M. H. Wolff. 2005. ORF 61 protein of varicella-zoster virus influences JNK/SAPK and p38/MAPK phosphorylation. J. Med. Virol. 76:424-433.
62. Rahaus, M., N. Desloges, and M. H. Wolff. 2004. Replication of varicella-zoster virus is influenced by the levels of JNK/SAPK and p38/MAPK activation. J. Gen. Virol. 85:3529-3540.
63. Rahaus, M., and M. H. Wolff. 2000. Transcription factor Sp1 is involved in the regulation of varicella-zoster virus glycoprotein E. Virus Res. 69:69-81.
64. Rahaus, M., and M. H. Wolff. 2003. Reciprocal effects of varicella-zoster virus (VZV) and AP1: activation of jun, fos and ATF-2 after VZV infection and their importance for the regulation of viral genes. Virus Res. 92:9-21.
65. Rodriguez, J. E., T. Moninger, and C. Grose. 1993. Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody. Virology 196: 840-844.
66. 1 phase cell cycle machinery. Bioessays 22:818-826.
67. Santibanez, J. F., and C. Hurtado. 2005. Ha-Ras sensitizes transformed mouse skin cells to anisomycin-induced apoptosis. FEBS Lett. 579:6459-6464.
68. Taylor, S. L., P. R. Kinchington, A. Brooks, and J. F. Moffat. 2004. Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus. J. Virol. 78:2853-2862.
69. Theodosiou, A., and A. Ashworth. 2002. MAP kinase phosphatases. Genome Biol. 3:REVIEWS3009.
70. Wang, G., J. W. Barrett, M. Stanford, S. J. Werden, J. B. Johnston, X. Gao, M. Sun, J. Q. Cheng, and G. McFadden. 2006. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. Proc. Natl. Acad. Sci. USA 103:4640-4645.
71. Whitmarsh, A. J., and R. J. Davis. 2001. Analyzing JNK and p38 mitogen-activated protein kinase activity. Methods Enzymol. 332:319-336.
72. Xia, Y., and M. Karin. 2004. The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol. 14:94-101.
73. Yao, F., and R. J. Courtney. 1989. A major transcriptional regulatory protein (ICP4) of herpes simplex virus type 1 is associated with purified virions. J. Virol. 63:3338-3344.
74. Zachos, G., B. Clements, and J. Conner. 1999. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J. Biol. Chem. 274:5097-5103.